Malignant Fibrous Histiocystoma Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Histiocytosis Program

Summary

Boston Children's Hospital and Dana-Farber Cancer Institute are also conducting numerous research studies to help better understand and treat soft tissue and bone sarcomas.

Research Underway

Types of treatment currently being studied include:

  • We are studying angiogenesis inhibitors, substances that may be able to prevent the growth of tumors.
  • We are also studying biological therapies, a wide range of substances that may be able to involve the body's own immune system to fight cancer or lessen harmful side effects of some treatments.
  • Researchers are looking into neoadjuvant chemotherapy and radiotherapy, treatments using chemotherapy and radiotherapy before resecting the primary tumor are being investigated.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close